DNA Chip Research Inc.
Tokyo Stock ExchangeTotal Valuation
DNA Chip Research Inc. carries a market capitalization of 7.38B, placing it among publicly traded companies globally.
| Market Cap | 7.38B |
| Enterprise Value | N/A |
Share Statistics
DNA Chip Research Inc. currently has 6.76M shares outstanding.
| Shares Outstanding | 6.76M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 20.71, and the price-to-book ratio stands at -45.62.
| PE Ratio | N/A |
| PS Ratio | 20.71 |
| PB Ratio | -45.62 |
| P/TBV Ratio | 17.10 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Financial Position
DNA Chip Research Inc. maintains a current ratio of 3.24, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.24 |
| Quick Ratio | 1.86 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -26.79 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.84 |
Taxes
| Income Tax | 1.90M |
| Effective Tax Rate | N/A |
Stock Price Statistics
DNA Chip Research Inc.'s stock has gained approximately 9.52859% over the past 52 weeks. The 50-day moving average sits at 2.46B, while the 200-day moving average is 1.99B.
| Beta (5Y) | N/A |
| 52-Week Price Change | 9.52859% |
| 50-Day Moving Average | 2.46B |
| 200-Day Moving Average | 1.99B |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, DNA Chip Research Inc. generated 490.46M in revenue and converted that into -248.29M in net income, yielding earnings per share of -39.09. EBITDA reached -258.22M, while operating income came in at -258.22M.
| Revenue | 490.46M |
| Gross Profit | 66.35M |
| Operating Income | -258.22M |
| Pretax Income | -246.39M |
| Net Income | -248.29M |
| EBITDA | -258.22M |
| EBIT | -258.22M |
| Earnings Per Share (EPS) | -39.09 |
Balance Sheet
Total book value stands at -222.63M, with working capital of 468.26M providing operational flexibility.
| Cash & Cash Equivalents | 388.41M |
| Total Debt | N/A |
| Net Debt | -388.41M |
| Equity (Book Value) | -222.63M |
| Book Value Per Share | -35.05 |
| Working Capital | 468.26M |
Margins
DNA Chip Research Inc. operates with a gross margin of 13.53, reflecting its pricing power and cost economics. The operating margin of -52.65 and net profit margin of -50.62 provide insight into operational efficiency.
| Gross Margin | 13.53 |
| Operating Margin | -52.65 |
| Pretax Margin | -50.24 |
| Profit Margin | -50.62 |
| EBITDA Margin | -52.65 |
Stock Splits
DNA Chip Research Inc.'s most recent stock split took place on September 26, 2013 with a 1:100 split ratio.
| Last Split Date | 9/26/2013 |
| Split Ratio | 1:100 |
Scores
DNA Chip Research Inc. posts an Altman Z-Score of 22.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 22.69 |